Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Omipalisib | 0.031623 | uM | 4 | 1250.00 | 814.29 | 801.00 | 1665.50 | 0.4809 | -0.0158 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 4 | 1250.00 | 814.29 | 1422.00 | 1665.50 | 0.8538 | 0.7161 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 4 | 1250.00 | 814.29 | 1340.00 | 1665.50 | 0.8046 | 0.6201 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 4 | 1250.00 | 814.29 | 1005.00 | 1665.50 | 0.6034 | 0.2261 |
| SK-BR-3 | Taxol | 0.031623 | uM | 4 | 1250.00 | 814.29 | 778.00 | 1665.50 | 0.4671 | -0.0432 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 4 | 1250.00 | 814.29 | 624.00 | 1665.50 | 0.3747 | -0.2273 |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1995.00 | 1665.50 | 1.1978 | 1.3822 | |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1352.00 | 1665.50 | 0.8118 | 0.6342 |
| SK-BR-3 | Taxol | 1 | uM | 4 | 1250.00 | 814.29 | 639.00 | 1665.50 | 0.3837 | -0.2093 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 4 | 1250.00 | 814.29 | 1204.00 | 1665.50 | 0.7229 | 0.4606 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1047.00 | 1665.50 | 0.6286 | 0.2757 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 4 | 1250.00 | 814.29 | 1624.00 | 1665.50 | 0.9751 | 0.9517 |
| SK-BR-3 | Omipalisib | 10 | uM | 4 | 1250.00 | 814.29 | 425.00 | 1665.50 | 0.2552 | -0.4673 |
| SK-BR-3 | Methotrexate | 1 | uM | 4 | 1250.00 | 814.29 | 1288.00 | 1665.50 | 0.7733 | 0.5592 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1678.00 | 1665.50 | 1.0075 | 1.0145 |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1662.00 | 1665.50 | 0.9979 | 0.9959 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1287.00 | 1665.50 | 0.7727 | 0.5580 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1312.00 | 1665.50 | 0.7878 | 0.5873 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1589.00 | 1665.50 | 0.9541 | 0.9110 | |
| SK-BR-3 | Taxol | 0.01 | uM | 4 | 1250.00 | 814.29 | 564.00 | 1665.50 | 0.3386 | -0.2994 |
| SK-BR-3 | Taxol | 0.1 | uM | 4 | 1250.00 | 814.29 | 527.00 | 1665.50 | 0.3164 | -0.3439 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1381.00 | 1665.50 | 0.8292 | 0.6681 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 4 | 1250.00 | 814.29 | 1797.00 | 1665.50 | 1.0790 | 1.1528 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 1250.00 | 814.29 | 952.00 | 1665.50 | 0.5716 | 0.1634 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 1250.00 | 814.29 | 633.00 | 1665.50 | 0.3801 | -0.2165 |